Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmen...

por Buechler, Steven A, Gray, Kathryn P, Gökmen-Polar, Yesim, Willis, Scooter, Thürlimann, Beat, Kammler, Rosita, Viale, Giuseppe, Leyland-Jones, Brian, Badve, Sunil S, Regan, Meredith M
Publicado 2019

Transcriptome analysis reveals overlap in fusion genes in a phase I clinical cohort of TNBC and HGSOC patients treated with buparlisib and olaparib

por Eismann, Julia, Heng, Yujing J., Waldschmidt, Johannes M., Vlachos, Ioannis S., Gray, Kathryn P., Matulonis, Ursula A., Konstantinopoulos, Panagiotis A., Murphy, Charles J., Nabavi, Sheida, Wulf, Gerburg M.
Publicado 2019

Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expression

por Lalani, Aly-Khan A., Gray, Kathryn P., Albiges, Laurence, Callea, Marcella, Pignon, Jean-Christophe, Pal, Soumitro, Gupta, Mamta, Bhatt, Rupal S., McDermott, David F., Atkins, Michael B., Woude, G.F. Vande, Harshman, Lauren C., Choueiri, Toni K., Signoretti, Sabina
Publicado 2017

Elevated APOBEC3B Correlates with Poor Outcomes for Estrogen-Receptor-Positive Breast Cancers

por Sieuwerts, Anieta M., Willis, Scooter, Burns, Michael B., Look, Maxime P., Gelder, Marion E. Meijer-Van, Schlicker, Andreas, Heideman, Marinus R., Jacobs, Heinz, Wessels, Lodewyk, Leyland-Jones, Brian, Gray, Kathryn P., Foekens, John A., Harris, Reuben S., Martens, John W. M.
Publicado 2014

Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial

por Johansson, Harriet, Gray, Kathryn P., Pagani, Olivia, Regan, Meredith M., Viale, Giuseppe, Aristarco, Valentina, Macis, Debora, Puccio, Antonella, Roux, Susanne, Maibach, Rudolf, Colleoni, Marco, Rabaglio, Manuela, Price, Karen N., Coates, Alan S., Gelber, Richard D., Goldhirsch, Aron, Kammler, Roswitha, Bonanni, Bernardo, Walley, Barbara A.
Publicado 2016

High Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple Cancers

por Willis, Scooter, Sun, Yuliang, Abramovitz, Mark, Fei, Teng, Young, Brandon, Lin, Xiaoqian, Ni, Min, Achua, Justin, Regan, Meredith M., Gray, Kathryn P., Gray, Robert, Wang, Victoria, Long, Bradley, Kammler, Roswitha, Sparano, Joseph A., Williams, Casey, Goldstein, Lori J., Salgado, Roberto, Loi, Sherene, Pruneri, Giancarlo, Viale, Giuseppe, Brown, Myles, Leyland-Jones, Brian
Publicado 2017